[Optimizing treatment of osteoporosis. Rapidly effective therapy lowers fracture risk in 1 year up to 70%].
D000368:Aged; D000369:Aged, 80 and over; D017326:Clinical Trials, Phase III as Topic; D012968:Etidronic Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D005260:Female; D005500:Follow-Up Studies; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D000068296:Risedronic Acid; D012307:Risk Factors
D000068296:Risedronic Acid; D012968:Etidronic Acid